Sign inJoin waitlistJoin the waitlist

DC

Dow-Chung Chi

Hematology & Oncology

Credentials: · ·

History

Hematology and Medical Oncology
Internal Medicine

Research

Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis
The Lancet Oncology · 2018 · 143 citations
FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen
Clinical Cancer Research · 2017 · 63 citations
Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
Breast Cancer Research and Treatment · 2021 · 24 citations

RP
Richard Pazdur
4 papers
DS
Daniel Suzman
3 papers
MT
Marc Theoret
3 papers
PK
Paul Kluetz
3 papers
AB
Amy Barone
2 papers
CW
Chana Weinstock
2 papers
MB
Michael Brave
2 papers
PK
Patricia Keegan
2 papers
Amy Tiersten
1 paper
Anupama Goel
1 paper
Dawn Hershman
1 paper
Della Makower
1 paper